Bowman and Brooke Logo


While our firm is best known for defending automobile manufacturers, our lawyers counsel an array of Global 500 clients in high-stakes, national litigation in a range of industries.

Medical Device and Pharmaceutical

Stethoscope on a clipboard with medicine.

Bowman and Brooke’s medical device and pharmaceutical litigation practice group of experienced trial lawyers serves as national coordinating counsel, lead trial counsel – including at bellwethers – regional, and local counsel. With a passion and drive for mastering complex medical, scientific, epidemiological, engineering and regulatory issues, we represent manufacturers in widely publicized, highly complex cases, including mass torts, involving medical devices, prescriptions, over-the-counter medications, biologics and legacy drugs. Bowman and Brooke’s lawyers deliver legal representation that is innovative, cost effective and complementary to our clients’ core business objectives.

  • We understand our clients’ business needs and consistently deliver results that complement core business objectives with a proven approach that includes:
  • Developing a formidable defense strategy, rooted in science and aligned with business objectives
  • Coordinating a team of lawyers to implement a unified plan
  • Deploying the right lawyers to efficiently work up multiple cases simultaneously
  • Preparing discovery protocols and conducting large-scale document productions
  • Selecting, evaluating and preparing expert witnesses nationwide
  • Assessing litigation risks, and the regulatory impact of litigations and creating potential contingency plans
  • Ensuring a cutting-edge and consistent legal and appellate strategy
  • Trying cases to juries

Whether assessing product warnings and package inserts to meet FDA compliance, briefing and pleading appeals in federal and state courts, presenting before the JPML, arguing for early dismissals for lack of product identification, opposing class certification or heading to trial, Bowman and Brooke’s medical device and pharmaceutical team has the depth and experience necessary to critically evaluate claims and aggressively defend our Life Sciences clients.

  • Oct 04, 2016
    October 14, 2016, CA
    Firm Chair Paul Cereghini commented in Law360 following a class certification denial involving Breg, Inc.'s cold therapy devices. In Stacey Lucas et al. v. Breg Inc. et al., plaintiffs sought a nationwide class certification alleging that Breg, Inc. provided false and misleading instructions regarding the use of its Polar Care 500 device. 
  • Apr 21, 2016
    Orange County, CA
    During a trial in the Superior Court of California, County of Orange, a judge granted a motion of non-suit in favor of Breg, Inc. in a case involving a Breg Pain Care 3000 pain pump. William Stovall v. Breg, Inc., Superior Court of California, for the County of Orange – Civil Complex Center, Case No. 37-2011-00059728, Judge William Claster presiding.
  • Mar 15, 2015
    In McKenna v. Breg, Inc., a California appellate court upheld a jury verdict for device maker Breg, Inc. after a three and a half week trial in the Superior Court for the State of California for the first bellwether case in the California infusion pump JCCP to go to trial, a jury returned a complete defense verdict in favor of Breg, Inc.
  • Feb 06, 2013

    Breg, Inc. received a decisive win on February 6, 2013 in the first bellwether case in the California infusion pump JCCP to go to trial.

  • Jul 02, 2012
    After two days of deliberations in pain pump case, the judge ordered a mistrial.
  • June 17, 2024

    For the 17th year in a row, Bowman and Brooke has achieved national rankings in The Legal 500. The firm is named to all four Product Liability Defense categories—Automotive, Consumer, Pharmaceutical/Medical Device and Toxic Tort. Additionally, many individual attorneys are recognized.

  • April 11, 2024
  • December 20, 2023
    Legal Alert
    We are thrilled to share that Angela Angotti's article, "Nutraceuticals and Social Media: FDA and FTC Like and Subscribe to the Next Big Trend in Litigation," has been published in the Food and Drug Law Institute’s Food and Drug Law Journal. This achievement was a collaborative effort with Michele Fields, Vice President and Senior Claim Consultant, Conner Strong & Buckelew.
  • November 17, 2023
    Legal Alert

    Since 1996, Michigan law has immunized drug manufacturers from product liability claims if the drug at issue was approved by FDA and included an FDA-compliant label. The Michigan legislature recently signaled an end to this unique state law feature with the passage of Senate Bill No. 410, which strikes wholesale the immunity provision from the Michigan Product Liability Act.

  • December 7, 2022

    New Brunswick Managing Partner Chris Carton will be a panelist on the topic of “Lessons Learned from this Year’s Top MDLs: Key Defense Strategies from 3M Ear Plugs, Opioids and Zantac MDLs” at this year's annual ACI Drug and Medical Device Litigation Conference. 

Integrated Services

In addition to providing stellar legal counsel, we integrate our provision of other key services with the work of our legal teams. The result? Highly effective and efficient client service.